Epiisopiloturine nanoencapsulation improve its oral bioavailability in the treatment of inflammatory bowel diseases-Reference-Cited by-同舟云学术

Epiisopiloturine nanoencapsulation improve its oral bioavailability in the treatment of inflammatory bowel diseases

Published:2023-10 Issue: Volume:179 Page:111159
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

de Almeida Viviane Pinheiro Alves,da Silva Tino Marcos Lino,da Silva Sousa João Janilson,da Costa Ana Clara Coelho,Rocha Danyela Maria Leal,da Graça Sales Furtado Maria,de Brito Tarcisio Vieira,dos Reis Barbosa André Luiz

Publisher

Elsevier BV

Subject

General Medicine

Reference38 articles.

1. Diagnosis and classification of ulcerative colitis;Conrad;Autoimmun Rev,2014

2. Acute severe ulcerative colitis: from pathophysiology to clinical management;Hindryckx;Nat Rev Gastroenterol Hepatol,2016

3. Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats;Cetinkaya;Tohoku J Exp Med,2005

4. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis;Hill;Mucosal Immunol,2010

5. Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium;Damiani;J Gastroenterol Hepatol,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epiisopiloturine possibly controls inflammation and accelerates wound healing;Medical Hypotheses;2024-10

2. Antimicrobial activity of nanoparticles based on carboxymethylated cashew gum and epiisopiloturine: In vitro and in silico studies;International Journal of Biological Macromolecules;2024-08